Clinical Trial Update: Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associated With Endometriosis [Phase 1]

View source ↗

Summary

An open-label Phase 1 trial of thalidomide for chronic pelvic pain in women with endometriosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Thalomid (thalidomide)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Endometriosis | Phase 1 | Status: TERMINATED